Using an Investigational Pharmaceutical Grade Cannabis Treat Pain in Cancer Patients
Cancer causes pain in up to 70% of the patients it affects, with over 33% of those patients describing pain as distressing or even intolerable. Our goal is to decrease and manage this pain and improve the overall quality of life for people with advanced cancer.
Recent advances in cannabinoid research have raised awareness about their therapeutic potential in pain management. Currently, cannabinoids have the potential to play an important role in the treatment of some symptoms experienced by cancer patients, including nausea and vomiting, insomnia, and Anorexia and Cachexia Syndrome. Alleviating some of the pain associated with cancer can potentially have beneficial effects on sleep disorders, depression and anxiety, handling daily activities, and general coping support.
When pharmaceutical grade cannabis is vaporized instead of smoked, the beneficial components can be inhaled without the generation of smoke. Also, cannabis has been long considered a low risk option in cancer patients with few and tolerable side effects. Participants will be trained on how to use the vaporizer to ensure it is used in the safest and most effective way.